Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2026 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Prog
March 30, 2026 08:00 ET | Source: Teva Pharmaceutical Industries Ltd

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia® (denosumab), to treat a variety of debilitating bone conditions.Teva’s proposed biosimilar...
March 25, 2026 08:00 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
March 05, 2026 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting

AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
February 27, 2026 10:52 ET | Source: Research and Markets

Generic and Biosimilar Pharmaceuticals Industry Report 2026, Individual Assessment of the Largest 1,120 Companies with the Top 50 Ranked by Market Share, Sales Growth, Gross Profit and Pre-tax Profit

Dublin, Feb. 27, 2026 (GLOBE NEWSWIRE) -- The "Generic and Biosimilar Pharmaceuticals - Industry Report" report has been added to ResearchAndMarkets.com's offering. Using an exclusive...
February 20, 2026 07:16 ET | Source: Research and Markets

State of the Life Sciences Industry, Q4 2025 Review - Unveils Key Trends and Opportunities in Pharma, Biopharma, Medical Devices, Cell Biology

Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "State of the Life Sciences Industry - Fourth Quarter Review" has been added to ResearchAndMarkets.com's offering. The latest quarterly research...
February 16, 2026 06:46 ET | Source: Research and Markets

India Biosimilars Market Trends and Forecasts 2026-2035: Biologics Patent Expirations, Strategic Partnerships, and Government Incentives Driving Opportunities

Dublin, Feb. 16, 2026 (GLOBE NEWSWIRE) -- The "India Biosimilars Market: Industry Trends and Global Forecasts - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution...
February 04, 2026 12:54 ET | Source: Research and Markets

Oncology Biosimilars Research and Global Forecast Report 2025-2030: Targeted Therapies, Emerging Market Expansion, and Novel Biosimilar Formulations Drive Growth

Dublin, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Market" report has been added to ResearchAndMarkets.com's offering.The global market for oncology biosimilars is estimated to...
January 21, 2026 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
January 13, 2026 03:15 ET | Source: Bio Usawa Inc

Bio Usawa Receives Ghana FDA Approval for BioUcenta™

ACCRA, Ghana and KIGALI, Rwanda, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa, Inc.) today announced that the Ghana Food and Drugs Authority (Ghana FDA) has approved...